Kenvue Inc.(KVUE)
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Latest News & Analysis
Kenvue's Strategic Overhaul: Navigating Growth Challenges
A deep dive into Kenvue's strategic moves, financial health, and market challenges. Discover how 'Extraordinary Powers' and celebrity endorsements aim to drive growth.
Kenvue (KVUE): Strategic Growth, Dividend Sustainability, and Market Resilience
Kenvue Inc. navigates the consumer healthcare market with strategic moves, innovation, and activist investor engagement. Dividend sustainability and market resilience are key focuses.
Kenvue (KVUE) Analysis: New Headquarters, Starboard, Financials
Analysis of Kenvue's strategic shifts, new headquarters, Starboard Value's influence, and financial outlook. Key insights into growth, health, and economic resilience.
Kenvue (KVUE): Navigating Market Volatility, Board Changes, and Dividend Dilemmas
Analysis of Kenvue's (KVUE) board changes, skin health strategy, recession risks, and dividend sustainability. Includes valuation metrics and clinical data insights.
Kenvue: Clinical Data, Governance Changes, and Financial Outlook
Analysis of Kenvue's clinical data, governance changes with Starboard, dividend sustainability, and recession resilience, providing a comprehensive overview of its position and prospects.
Kenvue Inc. Financial Analysis: Strategic Shifts and Cost-Cutting Insights
A detailed data-driven analysis of Kenvue Inc.'s cost-saving initiatives, board changes, financial performance, and competitive market dynamics.
Kenvue Inc. (KVUE): Market Analysis, Challenges, and Future Outlook
A comprehensive analysis of Kenvue Inc.'s market position, challenges, and future prospects, focusing on strategic shifts, dividend sustainability, and market dynamics.
Kenvue Inc. (KVUE): Strategic Analysis, Financial Performance, and Future Outlook
A comprehensive analysis of Kenvue Inc. (KVUE), examining its CAGNY conference presentation, Starboard Value's impact, Q4 2024 earnings, and future outlook.
Kenvue's Post-Spin-Off Strategy: Challenges & Growth
A detailed analysis of KVUE’s post-spin-off performance, dividend sustainability, cost-cutting initiatives, and market trends in 2025.
Kenvue's 2025 Turnaround: Cost Cuts & Brand Revival
A comprehensive intraday analysis of Kenvue's performance, strategy, and market position as of February 20, 2025, focusing on data-driven insights and key developments.
Kenvue's 2025 Outlook: Challenges and Turnaround Strategies
A deep-dive analysis of Kenvue's Q4 2024 performance, 2025 outlook, cost-cutting initiatives, and brand turnaround measures.